MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-27-2026
Retractable Technologies Cash and Cash Equivalents 2011-2026 | RVP
Annual Cash and Cash Equivalents Retractable Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.59 M | 4.24 M | 12.7 M | 19.7 M | 29.2 M | 17.6 M | 5.93 M | 9.65 M | 14.9 M | 16.2 M | 18 M | 22.1 M | 27.6 M | 26 M | 25.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.2 M | 2.59 M | 16.8 M |
Quarterly Cash and Cash Equivalents Retractable Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.44 M | 3.04 M | 3.38 M | 4.24 M | 3.92 M | 6.85 M | 10 M | 12.7 M | 11.3 M | 4.14 M | 6.36 M | 19.7 M | 13.4 M | 20.4 M | 43.1 M | 29.2 M | 16.4 M | 22.4 M | 30.9 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 5.93 M | 5.93 M | 5.93 M | 5.93 M | 9.65 M | 9.65 M | 9.65 M | 9.65 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 18 M | 18 M | 18 M | 18 M | 18 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 27.6 M | 27.6 M | 27.6 M | 26 M | 26 M | 26 M | 26 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 43.1 M | 3.04 M | 16.8 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
Milestone Scientific
MLSS
|
1.11 M | $ 0.32 | 1.78 % | $ 26.3 M | USA |
 |
Alcon
ALC
|
1.53 B | $ 76.12 | 0.44 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
1.17 M | $ 11.18 | 1.73 % | $ 27.1 M | USA |
 |
STERIS plc
STE
|
172 M | $ 222.27 | 0.23 % | $ 21.9 B | USA |
 |
iRhythm Technologies
IRTC
|
236 M | $ 126.75 | 3.6 % | $ 4.06 B | USA |
 |
The Cooper Companies
COO
|
111 M | $ 64.56 | 0.22 % | $ 12.9 B | USA |
 |
Repro Med Systems
KRMD
|
8.87 M | $ 4.06 | 2.53 % | $ 188 M | USA |
 |
Microbot Medical
MBOT
|
3.91 M | $ 2.17 | -1.36 % | $ 99.4 M |  Israel |
 |
Haemonetics Corporation
HAE
|
307 M | $ 61.14 | 1.93 % | $ 3.08 B | USA |
 |
electroCore
ECOR
|
7.04 M | $ 6.12 | -0.89 % | $ 51.9 K | USA |
 |
ICU Medical
ICUI
|
308 M | $ 123.04 | -1.43 % | $ 3.03 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.21 B | $ 26.8 | 0.04 % | $ 4.5 B | USA |
 |
Isoray
ISR
|
30.6 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.37 B | $ 474.78 | -1.54 % | $ 169 B | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 122.09 | 0.35 % | $ 5.91 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 178.62 | -0.01 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 10.87 | 5.33 % | $ 224 M | USA |
 |
Teleflex Incorporated
TFX
|
379 M | $ 136.17 | -0.29 % | $ 6.08 B | USA |
 |
Merit Medical Systems
MMSI
|
446 M | $ 67.44 | -1.66 % | $ 3.99 B | USA |
 |
Utah Medical Products
UTMD
|
85.8 M | $ 67.69 | 0.77 % | $ 219 M | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 22.92 | -0.43 % | $ 1.54 B | USA |
 |
West Pharmaceutical Services
WST
|
791 M | $ 302.34 | -1.16 % | $ 21.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
326 M | $ 11.88 | -0.29 % | $ 2.37 B | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 51.58 | -1.0 % | $ 170 M | USA |
 |
LeMaitre Vascular
LMAT
|
28.2 M | $ 115.33 | 1.66 % | $ 2.61 B | USA |
 |
Predictive Oncology
POAI
|
10.8 M | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
153 M | $ 26.33 | 2.57 % | $ 1.31 B | USA |
 |
BioLife Solutions
BLFS
|
95.4 M | $ 21.55 | 0.8 % | $ 993 M | USA |
 |
Stereotaxis
STXS
|
13.4 M | $ 1.94 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
1.97 B | $ 18.25 | 0.5 % | $ 9.36 B | USA |
 |
ResMed
RMD
|
274 M | $ 221.51 | 0.81 % | $ 32.4 B | USA |
 |
AtriCure
ATRC
|
167 M | $ 29.3 | 0.07 % | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
8.61 M | $ 6.53 | -4.88 % | $ 290 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 11.13 | 0.27 % | $ 455 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 150.96 | -0.76 % | $ 43.4 B | USA |
 |
Nephros
NEPH
|
4.31 M | $ 2.98 | 3.83 % | $ 31 M | USA |
 |
OraSure Technologies
OSUR
|
199 M | $ 2.96 | -1.5 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
751 M | $ 118.28 | 0.58 % | $ 6.59 M | USA |